← FDA Drug Approvals (Drugs@FDA)

IRBESARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2015-12-07

Drug application

FDA Application #

ANDA204774

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRBESARTAN

Generic name

IRBESARTAN

Active ingredients

IRBESARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2015-12-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown